Related Experiment Video
Updated: Jul 13, 2026

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
Published on: January 4, 2012
EGF-induced apoptosis in A431 cells is dependent on STAT1, but not on STAT3
Pavel S Grudinkin1, Valery V Zenin, Andrey V Kropotov
1Department of Intracellular Signalling and Transport, Institute of Cytology RAS, 194064 St. Petersburg, Russia. paulsg@rbcmail.ru
Abstract:
EGF in high concentrations has a growth-inhibitory effect on human epidermoid carcinoma cells A431. The transcription factor STAT1 is the most probable candidate for mediating this effect. In the present study, we demonstrated a strong reduction of the expression level of STAT1 in EGF-resistant sub-clones of A431 cells. EGF resistance was reversed by introducing wild-type STAT1, but not its Y701F mutant. Moreover, blocking the activity of Src family kinases reduced tyrosine phosphorylation of STAT1 and STAT3 and protected A431 cells from the EGF-induced growth inhibition. To further elucidate roles of STATs in A431 cell growth and survival, clones of A431 cells expressing short hairpin RNA (shRNA) against STAT1 or STAT3 were generated. Neither STAT1 nor STAT3 knockdown exerted any effect on growth rate or apoptotic death of A431 cells in the absence of EGF. However, upon EGF treatment A431 cells with knocked down STAT1 continued to grow and demonstrated a significantly lower level of apoptosis as compared to A431 cells. The knockdown of STAT3 did not alter cell growth or apoptosis. Taken together, our experiments prove the essential role of tyrosine phosphorylated STAT1, but not of STAT3, in EGF-induced apoptosis in A431 cells.
Insights
Epidermal Growth Factor (EGF) normally inhibits A431 cancer cell growth. This study reveals that Signal Transducer and Activator of Transcription 1 (STAT1) is crucial for this EGF-induced apoptosis, with STAT1 phosphorylation mediating the effect.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- High concentrations of Epidermal Growth Factor (EGF) inhibit the growth of human epidermoid carcinoma cells (A431).
- The transcription factor Signal Transducer and Activator of Transcription 1 (STAT1) is implicated in mediating this EGF-induced growth inhibition.
Purpose of the Study:
- To investigate the role of STAT1 in EGF-mediated growth inhibition and apoptosis in A431 cells.
- To determine if STAT1 phosphorylation is essential for the anti-proliferative effects of EGF.
Main Methods:
- Generated EGF-resistant A431 sub-clones and reintroduced wild-type or mutant STAT1.
- Utilized short hairpin RNA (shRNA) to knock down STAT1 and STAT3 expression in A431 cells.
- Assessed cell growth, apoptosis, and STAT1/STAT3 tyrosine phosphorylation levels.
Main Results:
- EGF-resistant cells showed reduced STAT1 expression; reintroducing wild-type STAT1 restored EGF sensitivity.
- STAT1 knockdown prevented EGF-induced apoptosis and allowed continued cell growth.
- Blocking Src family kinases reduced STAT1/STAT3 phosphorylation and protected cells from EGF-induced growth inhibition.
Conclusions:
- Tyrosine-phosphorylated STAT1, not STAT3, is essential for EGF-induced apoptosis in A431 cells.
- STAT1 plays a critical role in mediating the growth-inhibitory and apoptotic effects of EGF in this cancer cell line.
Related Concept Videos
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Regulation of Angiogenesis and Blood Supply
Intracellular Signaling Affects Focal Adhesions
Some...
Amplifying Signals via Enzymatic Cascade
Mitogens and the Cell Cycle
